Promises
2 promises
Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →Dabur India Limited — Q3 FY24
Dabur delivered a solid Q3 with consolidated revenue of INR 3,255 crore (+7% YoY) and 6% volume growth in India FMCG.
bullish
high
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Dabur delivered a solid Q3 with consolidated revenue of INR 3,255 crore (+7% YoY) and 6% volume growth in India FMCG. Gross margin expanded 310 bps on material deflation, while operating profit grew 9.5% with 50 bps margin expansion. International business grew 11.7% in CC, led by MENA and Egypt. Rural growth outpaced urban by 200 bps, driven by distribution expansion to 1.17 lakh villages and 18,700 Yoddhas. The healthcare portfolio was muted due to delayed winters, but HPC and oral care gained market share. Management remains cautiously optimistic, guiding for continued margin expansion and rural recovery. Key risk: sustained food inflation could pressure rural demand and delay recovery.
डाबर ने तीसरी तिमाही में अच्छा प्रदर्शन किया। कंपनी की कुल कमाई 3,255 करोड़ रुपये रही, जो पिछले साल से 7% ज्यादा है। भारत में एफएमसीजी कारोबार में बिक्री की मात्रा 6% बढ़ी। कच्चे माल की कीमतें सस्ती होने से कंपनी का मुनाफा बढ़ा और परिचालन लाभ 9.5% बढ़ा। अंतरराष्ट्रीय कारोबार में 11.7% की वृद्धि हुई, खासकर मध्य पूर्व और मिस्र में। गांवों में बिक्री शहरों से ज्यादा बढ़ी, क्योंकि कंपनी ने 1.17 लाख गांवों तक पहुंच बनाई। हेल्थकेयर उत्पादों की बिक्री कम रही, लेकिन होम केयर और ओरल केयर में बाजार हिस्सेदारी बढ़ी। प्रबंधन सावधानी से आशावादी है और मुनाफा बढ़ने तथा गांवों में सुधार की उम्मीद करता है। खतरा: खाने-पीने की चीजों की महंगाई गांवों की मांग को कम कर सकती है।
Promises0 met · 2 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
Delayed winter impacting healthcare portfolio
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
India FMCG Volume Growth
6%
+6% YoY
Volume growth in India FMCG business including Badshah, driven by rural expansion and portfolio initiatives.
International Business CC Growth
11.7%
+11.7% YoY
Constant currency growth led by MENA (+14.3%), Egypt (+43%), and Turkey (+43.8%).
Gross Margin Expansion
310 bps
+310 bps YoY
Expansion driven by material deflation; A&P investments increased 36% to support brands.
Direct Reach
1.42M outlets
+200K outlets YoY
Direct distribution reach expanded to 1.42 million outlets, targeting 1.5 million by year-end.
What Changed vs Last Quarter
NEW
EBITDA margin expansion to continue in Q4
Management expects Q4 EBITDA margin expansion to be higher than the 50 bps seen in the first nine months, despite seasonal mix effects.
NEW
Legal costs to reduce in FY25
Legal costs related to the U.S. case are expected to be lower in FY25 due to a change to more cost-effective lawyers.
UPDATED
Foods portfolio run rate of INR 500 crore by year-end
Management committed to exiting the fiscal year with a run rate of INR 500 crore from the foods portfolio, including Badshah.
UPDATED
Direct reach target of 1.5 million outlets by fiscal year-end
Direct distribution reach to increase from 1.42 million to 1.5 million outlets by end of FY24.
DROPPED
Annual operating margin guidance of ~19.5%
Management reiterated commitment to ~19.5% annual operating margin despite INR 63 crore legal cost in H1 and recurring costs of ~INR 20 crore per quarter.
DROPPED
International business to sustain high double-digit constant currency growth in H2
Management expects international business to continue high double-digit constant currency growth in second half, barring escalation of Middle East conflict.
NEW RISK
Delayed winter impacting healthcare portfolio
Muted and delayed winters led to flat growth in Chyawanprash, though inventory is expected to clear in Q4.
NEW RISK
Sustained food inflation pressuring rural demand
Food inflation in fruits, vegetables, spices, and cereals remains high, potentially delaying rural recovery despite Dabur's outperformance.
NEW RISK
Legal case uncertainty and ongoing costs
The U.S. patent litigation continues to incur legal costs (~INR 20 crore per quarter), though scope has been narrowed and insurance may cover final damages.
NEW RISK
Q4 margin seasonality risk
Historical Q4 margins are lower due to product mix; management expects expansion but sequential decline is possible.
RISK GONE
Namaste LLC litigation costs and business impact
Ongoing multi-district litigation in US against hair relaxer industry could result in continued legal costs (~INR 20 crore/quarter for ~2 years) and potential revenue loss from relaxer portfolio (25% of Namaste's $45-50M business).
RISK GONE
Middle East conflict escalation
If the Israel-Hamas war spreads to the broader region, Dabur's international business (MENA region grew 18.4% in Q2) could be adversely impacted.
RISK GONE
South India rural weakness and credit issues
South India rural market is lagging due to poor monsoon and credit extension issues, with inventory build-up and delayed payments affecting business.
RISK GONE
Beverage business competitive pressure
New entrant Storia in coconut water impacted Dabur's market share in modern trade; recovery depends on aseptic PET bottle capex (INR 30-40 crore) which may take time to yield results.
🤫 Topics management stopped discussing
Mentioned in Q1 FY24, Q2 FY24
Despite high spice inflation, Dabur remains committed to exiting the fiscal year with a run rate of INR 500 crore from its foods portfolio.
Mentioned in Q1 FY24, Q2 FY24
Management expects international business to continue high double-digit constant currency growth in second half, barring escalation of Middle East conflict.
Fast read
Guidance and risk preview
Management committed to exiting the fiscal year with a run rate of INR 500 crore from the foods portfolio, including Badshah.
Muted and delayed winters led to flat growth in Chyawanprash, though inventory is expected to clear in Q4.
View Risks →